About The Author

Lars Grøntved obtained a PhD in Molecular Biology from the University of Southern Denmark in 2008. He did postdoctoral research with Gordon Hager at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, USA. Here he used functional genomics technology (e.g. DNase-seq and ChIP-seq) to study basic mechanisms regulating transcription factor (focus of Nuclear hormone receptors) interaction with chromatin. He specifically developed technology to probe for chromatin accessibility in tissue and collaborated with several NIH investigators to implement the technology. For his research at NIH he received a NCI Directors Intramural Innovation Award and a NIH Directors Award. In 2014 he joined the Department of Biochemistry and Molecular Biology at SDU as an Assistant Professor.